Vaccination in Patients with Chronic Lymphocytic Leukemia: Current Problems

Vaccination in Patients with Chronic Lymphocytic Leukemia: Current Problems

Relevance. Infections are the most common complication of chronic lymphocytic leukemia (CLL). According to registry studies, infections are the cause of death in 10–20% of patients. The emergence of new therapies for CLL has led to a decrease in mortality due to CLL progression, while mortality from...

Full description

Bibliographic Details
Main Authors:	M. I. Kislova, A. A. Petrenko, M. P. Kostinov, E. A. Nikitin
Format:	Article
Language:	Russian
Published:	Numikom LLC 2021-07-01
Series:	Эпидемиология и вакцинопрофилактика
Subjects:	хронический лимфолейкоз вторичный иммунодефицит вакцинация пневмококковая вакцина антигриппозная вакцина недостаточность специфических антител
Online Access:	https://www.epidemvac.ru/jour/article/view/1294

Similar Items

Immunogenicity and efficiency of a 23-valent pneumococcal vaccine in patients with rheumatoid arthritis: results of a 5-year follow up study
by: D. V. Bukhanova, et al.
Published: (2018-12-01)

Vaccination as a solution of the issue of resistance S. pneumoniae
by: H. P. Ruban, et al.
Published: (2021-05-01)

The effectiveness of immunization of children against Pneumococcal infection in Penza, Russia
by: O. N. Lesina, et al.
Published: (2019-04-01)

Experience in Immunizing HIV-Infected Children against Pneumococcal Infection and Influenza
by: O. I. Nazarova, et al.
Published: (2020-09-01)

Efficacy and Safety of Immunization With Pneumococcal Polysaccharide Vaccine in Children With Juvenile Idiopathic Arthritis: Preliminary Results of a Prospective Open-Label Study
by: Ekaterina I. Alexeeva, et al.
Published: (2017-06-01)

THE EXPERIENCE OF PNEUMOCOCCAL CONJUGATE VACCINE USAGE IN ORPHANAGE INSTITUTION OF THE REPUBLIC OF MORDOVIA
by: A. A. Brovkina, et al.
Published: (2012-11-01)

The Effect of Different Regimens of Vaccination against Pneumococcal Infection on the Clinical Course of Chronic Obstructive Pulmonary Disease: Focus on Changes in Sputum Microorganism Population
by: M. P. Kostinov, et al.
Published: (2021-08-01)

Immunization With a Pneumococcal Polysaccharide Vaccine in Children With Juvenile Idiopathic Arthritis Without Systemic Manifestations: a Prospective Study
by: Ekaterina I. Alexeeva, et al.
Published: (2018-01-01)

THE RESULTS OF STUDY OF THE LEVELS OF SPECIFIC ANTIBODIES TO THE COMBINED INJECTION VACCINES AGAINST INFLUENZA, MEASLES, RUBELLA AND MUMPS AND DT IN CHILDREN WITH CHRONIC PHYSICAL ILLNESS
by: S. M. Haritе, et al.
Published: (2015-08-01)

Assessment of Safety, Immunogenicity and Preventive Efficacy of Prevenar-13 in Children with Bronchopulmonary Dysplasia
by: E. S. Zubova, et al.
Published: (2018-04-01)

13-valent Pneumococcal Conjugate Vaccine and Haemophilus Influenzae-Tetanus Toxoid Conjugate Vaccine in Patient with Systemic Juvenile Idiopathic Arthritis Receiving Tocilizumab: Clinical Case
by: Ekaterina I. Alekseeva, et al.
Published: (2019-09-01)

Modern approaches to the prevention of pneumococcal infection
by: S. M. Kharit, et al.
Published: (2015-12-01)

Experience of Vaccination of a Patient with Systemic Juvenile Idiopathic Arthritis (sJIA) with a 13-Valent Pneumococcal Conjugate Vaccine, prior to the Appointment of Therapy with Tocilizumab, an Anti-IL-6-Receptor Monoclonal Antibody
by: Daria D. Vankova, et al.
Published: (2018-10-01)

Pertussis vaccination: problems, possible solutions
by: S. M. Kharit, et al.
Published: (2020-06-01)

Prevention of Pneumococcal Infection in Children with Chronic Diseases of the Nasopharynx Reduces the Incidence of Other Respiratory Tract Infections: Results of a Comparative Prospective Study
by: V. P. Vavilova, et al.
Published: (2015-11-01)

Cost-effectiveness of vaccination against pneumococcal infection of adults at risk within the federal and regional programs
by: A. V. Rudakova, et al.
Published: (2019-12-01)

The effectiveness of pneumococcal vaccination and dynamics of acute otitis media incidence in children
by: G. M. Letifov, et al.
Published: (2019-11-01)

New Arguments in favor of the Release Active Antiviral Drug to Prepare Children for Vaccination
by: V. P. Vavilova, et al.
Published: (2015-12-01)

Pharmacoeconomic aspects of vaccination against Pneumococcal Infection in Russia
by: A. V. Rudakova, et al.
Published: (2014-09-01)

ТHE LEVEL OF ANTIBODIES TO THE INFLUENZA VIRUS IN PREGNANT WOMEN VACCINATED WITH SUBUNIT VACCINE
by: M. P. Kostinov, et al.
Published: (2018-01-01)

INFLUENZA VACCINATION OF CHILDREN OF PRESCHOOL AGE IN THE RUSSIAN FEDERATION: COST-EFFECTIVENESS OF QUADRIVALENT VACCINE
by: A. V. Rudakova, et al.
Published: (2019-03-01)

Immunological Efficacy and Safety of a New Pneumococcal Polysaccharide Conjugated Thirteen-Valent Vaccine in the Immunization of Adults and Children (Results of Clinical Studies in the Russian Federation)
by: I. V. Feldblium, et al.
Published: (2022-11-01)

PHARMACOECONOMIC ASSESSMENT OF 13-VALENT PNEUMOCOCCAL CONJUGATE VACCINE IN IMMUNIZATION OF CHILDREN IN RUSSIAN FEDERATION
by: A. V. Rudakova, et al.
Published: (2014-01-01)

Efficacy of usage of pneumococcal 7-valent vaccine in prophylaxis of pneumococcal infection in Novosibirsk children from risk groups
by: O. A. Beletskaya, et al.
Published: (2013-03-01)

The Use of 23-Valent Pneumococcal Polysaccharide Vaccine in Patients with Rheumatoid Arthritis
by: M. S. Naumtseva, et al.
Published: (2015-08-01)

Epidemiological and etiological characteristics of community-acquired pneumonia in conscripts in the modern period. Comparative evaluation of the effectiveness of pneumococcal vaccines
by: P. V. Kulikov, et al.
Published: (2019-05-01)

SAFETY AND IMMUNOLOGIC EFFICACY OF COMBINED IMMUNIZATION IN CHILDREN AGED 6—7 YEARS WITH VACCINES FROM THE NATIONAL CALENDAR OF PROPHYLACTICS VACCINES
by: I. V. Konovalov, et al.
Published: (2015-08-01)

Evolution of the national vaccination calendar. Results and prospects
by: O. V. Shamsheva
Published: (2022-03-01)

Evaluation of Seasonal Inactivated Influenza Vaccines Prophylactic Efficacy
by: K. V. Zhdanov, et al.
Published: (2022-11-01)

Safety and efficacy of 23-valent polysaccharide pneumococcal vaccine in patients with systemic lupus erythematosus
by: G. M. Tarasova, et al.
Published: (2021-06-01)

Optimization of chronic lymphocytic leukemia treatment using game theory
by: A. S. Luchinin, et al.
Published: (2021-12-01)

The averted costs due to influenza vaccination with trivalent and quadrivalent vaccines
by: S. M. Kharit, et al.
Published: (2017-06-01)

RESULTS OF THE IMMUNIZATION ACCORDING TO THE NATIONAL CALENDAR ASSOCIATED WITH VACCINATION AGAINST INFLUENZA IN CHILDREN WITH SOMATIC DISORDERS AND IMMUNODEFICIENCY
by: S. M. Kharit, et al.
Published: (2014-01-01)

Vaccine prevention of rotavirus infection: Social significance and effectiveness
by: A. G. Yuzhakova, et al.
Published: (2017-06-01)

VACCINATION AGAINST ROTAVIRUS INFECTION AS A CONTRIBUTION TO CHILDREN'S HEALTH
by: A. G. Yuzhakova, et al.
Published: (2017-12-01)

Vaccination against Pneumococcal Infections of High-Risk People: Pharmacoeconomic Aspects
by: A. V. Rudakova, et al.
Published: (2020-01-01)

Efficacy and Safety of Peptide Vaccine in Prevention of SARS-CoV-2 Infection: Prospective Study among Healthcare Professionals
by: Leyla S. Namazova-Baranova, et al.
Published: (2022-05-01)

New coronavirus infection in a child with severe secondary immunodeficiency associated with hematopoietic stem cell transplantation against the background of acute lymphoblastic leukemia
by: S. M. Bezrodnova, et al.
Published: (2022-10-01)

Results of Clinical Trials of the First Russian 4-valent Flu Vaccine
by: D. A. Lioznov
Published: (2018-09-01)

Immunization Str.pneumonia vaccine reduces the incidence orphanage children’s acute otitis media (preliminary results)
by: A. A. Dzhumagaziev, et al.
Published: (2014-09-01)